Wednesday, December 31, 2014

Deal of the Week: 'Mile-High Rents Put Denver in Big-Time Company'

Quoting from the Dec 30th WSJ column by Max Taves:

"Apartment dwellers in New York, San Francisco and Boston often pay more in rent than average Americans spend on monthly home-mortgage payments.

Is it time to add Denver to that list?

Perhaps, if you are talking about the 34-story glass luxury apartment tower near downtown Denver that is a venture of PM Realty Group and partner National Real Estate Advisors LLC."
 
Link to the full article at wsj.com

Tuesday, December 30, 2014

Denver PR News and Information: Top Blog Posts of 2014 Achieve 3,988 Page Views for Absolutely PR Client News

Absolutely PR's Denver PR News and Information reports the following top local client blog posts in 2014:

# 1 - TechFlash: 'Colorado bioscience organization searches for new leadership' for The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 11/24/14 – 365 Page Views

# 2 - Media Coverage: 'Kevin M. Smith to Retire as President & CEO of CID4; Search Committee Formed to Hire Smith’s Successor' for The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 11/25/14 – 325 Page Views

# 3 - InnovatioNews: 'Kevin Smith to retire from leadership of Colorado Institute for Drug, Device and Diagnostic Development on Dec. 31' for The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 11/24/14 – 249 Page Views

# 4 - DeviceSpace: 'Kevin M. Smith To Retire As President & CEO Of The Colorado Institute For Drug, Device And Diagnostic Development; Search Committee Formed To Hire Smith’s Successor' for The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 11/24/14 – 235 Page Views

# 5 - Well-known Life Science Executive Kevin M. Smith to Retire as President/CEO of Colorado Institute for Drug, Device and Diagnostic Development; Search Committee Formed to Hire Smith’s Successor for The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 11/24/14 – 234 Page Views

# 6 - Video Highlights: 2014 CBSA Awards Dinner for Colorado BioScience Association – 11/14/14 – 230  Page Views

# 7 - In The News: 'Dan Ritchie joins Fitzsimons Redevelopment Authority board' for Colorado BioScience Association and Fitzsimons Redevelopment Authority – 12/14/14 – 221 Page Views

# 8 - Headed to the Cherry Creek Arts Fest? Stop in PISMO and Say Hi to Red Hot Ruby for 2014 Tails of the Painted Cats and Cat Care Society – 7/3/14 – 193 Page Views

# 9 - Xconomy: Colorado Bioscience "Companies Take a Bow" for Colorado BioScience Association – 11/13/14 – 185 Page Views

# 10 - BioWest 2014 on Wed Sept 10: Expo Returns + Conference Welcomes FDA Commissioner Hamburg as Lead Keynote for BioWest 2014 and Colorado BioScience Association – 9/2/14 – 175 Page Views

# 11 - InnovatioNews: 'Three finalists selected for 2014 CBSA BioWest Venture Showcase pitch competition Sept. 10' for Colorado BioScience Association – 8/21/14 – 172 Page Views

# 12 - DrBicuspid: 'Sapphire Technology gets funding for filling instruments' for Sapphire Technology, The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 10/10/14 - 166 Page Views

# 13 - Beau Jo's Hosts Last Feasting for Felines of 2014 - Nov. 19 - five locations! For Cat Care Society – 11/11/14 – 165 Page Views

# 14 - Artists Call for Entry: Tails of the Painted Cats 2015 for 2015 Tails of the Painted Cats and Cat Care Society – 9/5/14 – 159 Page Views

# 15 - Pharmiweb: 'Colorado Institute for Drug Device and Diagnostic Development Awards Funding & Management Assistance to Sapphire Technology' for Sapphire Technology and The Colorado Institute for Drug Device and Diagnostic Development (CID4) – 10/15/14 – 154 Page Views

# 16 - Denver Post: "Tails of the Painted Cats comes together purr-fectly for Cat Care Society" for 2014 Tails of the Painted Cats and Cat Care Society – 8/6/14 – 153 Page Views

# 17 - Tails of Painted Cats Tower of Wine Is Back in the Silent Auction This Weekend for 2014 Tails of the Painted Cats and Cat Care Society – 7/21/14 – 153 Page Views

# 18 - Coverage overview: CBSA's 2014 Colorado Bioscience Industry Awards for Colorado BioScience Association – 11/14/14 – 146 Page Views

# 19 - CBSA Partners with PrIME Health Collaborative to Offer a BioWest 2014 Pre-Event for Colorado BioScience Association – 8/20/14 – 146 Page Views

# 20 - Sept 10: BioWest Includes State's Top BioScience CEOs + FDA Commissioner Hamburg as Lead Keynote for BioWest 2014 and Colorado BioScience Association - 8/28/14 – 142 Page Views

Year End Review: @COBioScience Top Ten Tweets of 2014 (based on Hootsuite click through data)

#1 22-Apr-14     
235 Clicks            
Denver Post: 'Boettcher Foundation awards $825,000 to CSU, CU Boulder and others' http://ow.ly/w3iQ8 @BoettcherFdn

#2 15-Jul-14       
63 Clicks              
DBJ: Med devices drive Colorado bioscience industry http://ow.ly/zc6Rz @GregAveryDenBiz #Colorado #MedDevice
#3 26-Jun-14     
43 Clicks
CBSA Applauds Colorado Companies to Watch for Honoring Five Local Bioscience Companies http://ow.ly/yuo4z #CCTW

#4 24-Jul-14       
37 Clicks              
DBJ: '5 #Colorado cities among Forbes' 30 best places for business' #Denver #BusinessFriendly http://ow.ly/zy4yA @MHardenDenBiz

#5 29-May-14   
30 Clicks              
#Colorado Gov Hickenlooper signs HB 14-1012, Advanced Industry Investor Tax Credit Program http://ow.ly/xpm8u @HickenlooperNow

#6 7-Jul-14         
28 Clicks              
New #Colorado Bioscience Company #Directory http://ow.ly/yS5K4 #AKeeper #File #NewMagazine

#7 1-Jul-14         
24 Clicks              
#Colorado: Advanced Industry Accelerator Program Announces Close to $2 Million in Grants  http://ow.ly/yESjC @ColoradoEcoDevo

#8 17-Sep-14     
24 Clicks              
Three #Colorado Companies Present at Inaugural White Hat Life Sci Investor Conference in Phoenix http://ow.ly/BCaKE

#9 27-Jan-14      
23 Clicks              
Denver Post: 'Beer science: Avery Brewing pairs with CU biotech lab to improve quality control' http://ow.ly/t0IF7  @BioFrontiers

#10 6-Aug-14    
22 Clicks              

Curious about #Colorado’s Sharklet? CompanyWeek Profiles This Week: http://ow.ly/A2eFI  #MedDevice #InfectionControl

Coverage: 'CBSA Names Primavera Group as PR rep following retirement of Absolutely PR's Maggie Holben'

Quoting from today's posting:

"The Primavera Group will assume media relations and strategic public relations for the Colorado BioScience Association (CBSA) following the departure of Absolutely Public Relations in that role due to the retirement of Maggie Holben, Absolutely PR’s owner...

...'We’re thrilled to welcome Sarah and her associates at the Primavera Group to our CBSA team,' said April Giles, CBSA president and CEO...

...Holben said she is only “semi-retiring” from the PR business and will keep Absolutely PR open but will take on fewer projects to allow for more time for family and travel."

Link to InnovatioNews

More coverage:








Link to BioSpace






Link to GotNewsWire

Monday, December 29, 2014

Aurora Sentinel: CID4 'bioscience boss in Aurora stepping down'

Quoting from this morning's posting by Quincy Snowdon:

"The leader of the Colorado Institute for Drug, Device and Diagnostic Development is stepping down at the end of 2014.

After helping to launch the life science-focused nonprofit in 2009, Kevin Smith, CEO of CID4, is retiring from his post as a part of a planned retirement.

'I’ve invested about seven years of my life into this project and I’m really proud of where we are,' Smith said. 'I’m indebted to the all of the people involved.'

Smith cited wanting to spend more time with his family and the end of the organization’s first five-year plan as the central reasons for his resignation."

Link to the Aurora Sentinel

Kevin Smith, president and CEO of the Colorado Institute for Drug, Device and Diagnostic Development, poses at his office Aug. 29, 2011, near the Anschutz Medical Campus in Aurora. (Heather L. Smith/Aurora Sentinel)

Colorado BioScience Association Names Primavera Group to Succeed Absolutely PR as Media Relations & Strategic Public Relations Consulting Firm

The Primavera Group will assume the media relations and strategic public relations contract for the Colorado BioScience Association (CBSA) beginning January 5, 2015. The announcement is made by CBSA President and CEO April Giles, who says, "We’re thrilled to welcome Sarah and her associates at the Primavera Group to our CBSA team. They will be taking over from Absolutely PR’s Owner/Principal Maggie Holben who is retiring as CBSA's PR Consultant after more than ten years of service to the organization as a board member, contract PR resource and volunteer. In 2006, Absolutely PR was named CBSA Partner of the Year during the annual Awards Dinner. While we will miss Maggie, we are excited for all that will unfold under Sarah and her team’s direction going forward.”

Primavera Group is a Colorado-based brand development and integrated strategic marketing communications company that serves clients in technology, communications, business consulting and other growth industries. The team develops high-impact strategies, innovative solutions and persuasive content to communicate clients’ stories and compel audiences to action. Their client list spans established Fortune 50 companies to promising start ups.

“Our clients turn to us for crisp thinking, quick execution and our senior-level expertise. We believe the proof is in our performance, and we are proud of our 100% repeat engagement track record. We’re the firm that our clients count on time and again to generate results. In turn, our Primavera team looks forward to representing Colorado’s thriving Bioscience Industry,” Eder said.

In the bioscience space, Primavera has worked with CBSA member company, Sharklet Technologies, for the past seven years, achieving key media placements internationally, nationally and locally for the Colorado-based medical technology company. Most notably Primavera has placed Sharklet on a PBS Nova segment, CBS News Sunday Morning, The Wall Street Journal, Fast Company, Wired, Discover Magazine, Inc Magazine, Popular Science, FierceBiotech, European Medical Device Manufacturer, the Discovery Channel and, the Jeopardy game show where Sharklet was included as a featured answer. For more information, visit http://sharklet.com/about-us/in-the-news and www.theprimaveragroup.com.

“I’ve worked with Sarah over the years and I’m simply thrilled to be able to pass CBSA’s PR baton to her and her team. I’m confident Sarah’s business and PR acumen is exactly what CBSA needs to take our organization to the next level in its awareness growth curve. While I’m retiring as CBSA’s PR consultant, I’m only semi-retiring from the PR business. I’ll continue to keep my Absolutely PR consulting firm open in the future, but will be taking on projects of a lesser scope than the CBSA contract to allow for more travel and time with my family,” Holben explains. For more information, visit: http://www.absolutelypr.com.

Link to the PR.com release posting

Link to the PitchEngine social media release

Wednesday, December 24, 2014

InnovatioNews + More: '2014 was a successful year for major bioscience financings, acquisitions and expansions'

Quoting from the Dec 23rd InnovatioNews:

"The Colorado BioScience Association (CBSA) reports the state attained a number of key financings, acquisitions and expansions in its bioscience industry in 2014. 'We’ve seen a number of exciting deals come to fruition in our Colorado bioscience community during 2014, which strengthens our state’s position as a national industry leader,' said April Giles, CBSA president and CEO. Link to InnovatioNews to review the year's highlights

Other coverage of Colorado's 2014 BioScience Successes:








Link to Yahoo! Finance







Link to BioSpace












Link to EIN News








Link to CNBC

December CBSA Focus: Featuring AFEX Global Payment and Risk Management Solutions

The December Colorado BioScience Association Focus Newsletter is now available, with AFEX Global Payment and Risk Management Solutions as the Company Spotlight and a preview of CBSA's January events.

"AFEX is a trusted global payment and risk management solutions specialist with a heritage that dates back to 1979. With offices throughout the Americas, Europe and Asia Pacific, AFEX operates seamlessly 24 hours a day, 7 days a week, in over 200 countries, trading more than $15bn in foreign exchange each year." Link to read full the article

January Events

Wed, Jan 7 - BioBreakfast with Davita Clinical Research - link to register

Thur, Jan 29 - Medical Device Symposium

Link to download the entire December Focus Newsletter.

Tuesday, December 23, 2014

The GEN 'Top 17 Serial Bio Entrepreneurs' List Includes Colorado's Michael Bristow and Marvin Caruthers

Quoting from the December 15th GEN posting:

"The average number of businesses launched by serial entrepreneurs has most often been quoted at 2.3, the figure furnished by the Kauffman Foundation for Entrepreneurship in 'The Anatomy of an Entrepreneur,' a 2009 study of 549 founders in industries that included biotechnology...Yet judging from this year’s updated GEN List of serial entrepreneurs, and the original List published in 2012, biotech entrepreneurs are among the most enterprising entrepreneurs."

Here are Colorado's contributors to our nation's the "serial bio entrepreneurs" fold:

Michael R. Bristow, M.D., Ph.D
Founded Myogen
Co-Founded miRagen and ARCA biopharma
Currently: Professor of Medicine in Cardiology and Co-Director of the University of Colorado Cardiovascular Institute at UC Denver School of Medicine

Marvin H. Caruthers, Ph.D.
Co-Founded miRagen Therapeutics, Array BioPharma, Applied Biosystems and Amgen
Served as Founding Investor for Dharmacon
Currently: Distinguished Professor of Chemistry and Biochemistry at the University of Colorado

Link to GEN

Monday, December 22, 2014

2014: Colorado's Major Bioscience Fundings + M&A Activity

Colorado attained a number of key financings, acquisitions and expansions in its bioscience industry during 2014. April Giles, President and CEO of the Colorado BioScience Association says: "We’ve seen a number of exciting deals come to fruition in our Colorado bioscience community during 2014, which strengthens our state’s position as a national industry leader. We’re thrilled that CBSA has continued to play a significant role in promoting Colorado as a dynamic region for bioscience innovation and investment.”

Highlighted Financings and Acquisitions in 2014 Include: 

* Terumo BCT broke ground on a 120,000-square-foot global headquarters building – April 1, 2014 Terumo BCT is building a 120,000-square-foot Global Headquarters building on its Lakewood campus. In 2015, when the building opens, Terumo BCT will occupy 90,000 square feet, leaving the additional space available for future growth and development. When complete, it will accommodate an estimated 400 associates. http://coloradocommunitymedia.com/stories/A-global-home,151084

* BioScience Park Center 2 groundbreaking adding 112,000 square foot building – April 4, 2014 The Fitzsimons Redevelopment Authority (FRA) and CU's Bioengineering program, design a multipurpose building for education, research and clinical care, with an added entrepreneurial element of private biosciences companies. Bioengineering students will have classes on the first two floors of the four-story building, and from there, the students will move up a floor and practice what they have learned and then move up again to begin their own commercial bioscience company on the top floor. http://www.ucdenver.edu/about/newsroom/newsreleases/Pages/Bioscience-2-groundbreaking-April-2014.aspx

* Spectranetics acquires California based AngioScore Inc. for $230 million in cash – June 30, 2014 Colorado Springs based Spectranetics Corporation (Nasdaq:SPNC) announced that it completed the acquisition of AngioScore Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons, for $230 million in cash, along with additional contingent commercial and regulatory milestone payments. http://globenewswire.com/news-release/2014/05/27/639682/10083292/en/Spectranetics-Announces-Agreement-to-Acquire-AngioScore-Inc.html

* Covidien to be acquired by Medtronic for $42.9B – June 16, 2014 Medtronic announced it will pay $42.9 billion in cash and stock to acquire Covidien and its medical-device lines in a deal expected to close in the fourth quarter or early 2015. Medtronic in Lousiville, and Covidien in Boulder, combined have over 2000 jobs in Colorado. http://www.massdevice.com/news/blockbuster-medtronic-43b-deal-acquire-covidien

* Clovis Oncology to offer $200M in convertible senior notes in private placement to investors – Sept 3, 2014 Boulder based Clovis Oncology Inc. announced it intended to offer $200 million aggregate principal amount of its convertible senior notes due 2021 in a private placement to qualified international buyers. http://innovationews.com/science/bioscience/clovis-oncology-to-offer-200m-in-convertible-senior-notes-in-private-placement-to-foreign-investors

* InDevR Wins $14.7M Barda Contract for Cutting-Edge Influenza Diagnostic – September 15, 2014 Boulder based InDevR announced that it signed a contract with the Biomedical Advanced Research and Development Authority (BARDA) to complete product development of their unique influenza diagnostic, FluChip-8G, which is capable of rapidly genotyping influenza viruses directly from clinical samples. http://www.marketwired.com/press-release/-1947252.htm

* SomaLogic announces Novartis agreement extension, equity investment – October 20, 2014 Boulder based SomaLogic, Inc. announced that Novartis has extended its multi-year research agreement for the development and application of SomaLogic’s unique proteomics technology to Novartis’ drug discovery and development efforts. Novartis will also take an equity position in SomaLogic under the agreement extension. http://www.somalogic.com/Resources/News-Events/News/2014/SomaLogic-announces-Novartis-agreement-extension,.aspx

* N30 Pharmaceuticals Secures $30 Million in Oversubscribed Crossover Financing – November 19, 2014 Boulder based N30 Pharmaceuticals, Inc. (“N30 Pharma”), a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis (CF), has raised $30 million in a mezzanine round of financing. Proceeds from the financing will primarily be used to advance the Company’s clinical trial program. New investors include Wellington Management, RA Capital Management, LLC, Jennison Associates LLC (on behalf of certain clients), Rock Springs Capital Management LP, and Sabby Management, LLC, who joined existing investor, Deerfield Management Company. http://www.prnewswire.com/news-releases/n30-pharmaceuticals-secures-30-million-in-oversubscribed-crossover-financing-283193921.html

Link to the Business Wire release

Link to the Pitch Engine social media newswire

Thursday, December 11, 2014

Cat Care Society Gift Wrappers Head to the LoDo Tattered Cover: Dec 14-21

December 14-21, Cat Care Society volunteers will again be wrapping gifts at the Historic LoDo location of Denver's iconic Tattered Cover Book Store, 1628 16th Street. Gift wrapping is free but tips are greatly appreciated and will be donated to the Cat Care Society shelter.

CCS volunteers will be in charge of the Tattered Cover's gift wrapping station on the following days: 

Sunday, December 14, 10 am to 4 pm

Monday, December 15, 10 am to 4 pm

Tuesday, December 16, 10 am to 4 pm

Wednesday, December 17, 10 am to 4 pm

Thursday, December 18, 10 am to 4 pm

Friday, December 19, 10 am to 4 pm

Saturday, December 20, 10 am to 4 pm

Sunday, December 21, 1 pm to 4 pm

 

Tuesday, November 25, 2014

Media Coverage: 'Kevin M. Smith to Retire as President & CEO of CID4; Search Committee Formed to Hire Smith’s Successor'

Coverage overview:


"The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement."
Link to BioPortfolio
"Kevin M. Smith will step down from his position as president and chief executive of the Colorado Institute for Drug, Device and Diagnostic Development, also known as CID4, on Dec. 31. The nonprofit bioscience charity has formed a search committee to find a new CEO, CID4 board Chairman Steve Orndorff said. Smith will be available through February to assist during the transition." Link to BizWest

Monday, November 24, 2014

TechFlash: 'Colorado bioscience organization searches for new leadership'

Quoting from today's Denver Business Journal posting by Greg Avery:

"The Colorado Institute for Drug, Device and Diagnostic Development is looking for a new CEO in advance of the retirement of Kevin Smith, the nonprofit group's current leader.

Smith is a co-founding executive of the Aurora-based nonprofit, known as CID4, that was started to help fill a gap in funding for bioscience startups. CID4 identifies and helps fund early-stage Colorado bioscience companies that have the potential to grow and create local jobs.

Smith, a former president of Gambro U.S.A., a Lakewood-based medical device company, plans to retire Dec. 31. He'll be available to the organization through February to help in the transition, the organization said. The CID4 board has formed a CEO search committee."

Link to the Denver Business Journal

InnovatioNews: 'Kevin Smith to retire from leadership of Colorado Institute for Drug, Device and Diagnostic Development on Dec. 31'

Quoting from this morning's posting:

"Kevin M. Smith, president and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his post on Dec. 31.

Steve Orndorff, chairman of the CID4 board and president and CEO of Micobiome Therapeutics, said the board has formed a search committee and that Smith will remain available through February 2015 to assist in a smooth transition for CID4’s new executive director...

...CID4 said all inquiries should be directed to the CID4 Search Committee at jobs@cid4.com. Deadline to apply is Dec. 20."

Link to InnovatioNews

DeviceSpace: 'Kevin M. Smith To Retire As President & CEO Of The Colorado Institute For Drug, Device And Diagnostic Development; Search Committee Formed To Hire Smith’s Successor'

Quoting from this morning's posting:

"Kevin M. Smith, President and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his position as Chief Executive Officer on December 31, 2014. The announcement is made by Steve Orndorff, PhD, Chairman of the CID4 Board and President & CEO of MicroBiome Therapeutics, who says the CID4 Board has formed a search committee and that Smith will be available through February 2015 to assist in a smooth transition for the new Executive Director."

Link to DeviceSpace

Well-known Life Science Executive Kevin M. Smith to Retire as President/CEO of Colorado Institute for Drug, Device and Diagnostic Development; Search Committee Formed to Hire Smith’s Successor

Kevin M. Smith to Retire as President & CEO of the Colorado Institute for Drug, Device and Diagnostic Development; Search Committee Formed to Hire Smith’s Successor

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement. Mr. Smith will remain with CID4 through February 2015 to ensure a smooth and successful transition for CID4’s new leader.

Aurora, CO November 24, 2014 – Kevin M. Smith, President and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his position as Chief Executive Officer on December 31, 2014. The announcement is made by Steve Orndorff, PhD, Chairman of the CID4 Board and President & CEO of MicroBiome Therapeutics, who says the CID4 Board has formed a search committee and that Smith will be available through February 2015 to assist in a smooth transition for the new Executive Director.

“With the ongoing changes in the healthcare and life science sectors, CID4 is revisiting how it can best support our industry,” Orndorff said. “CID4 is well positioned for its future and we believe the new Executive Director position will strengthen our alignment with the State of Colorado in our mutual quest to create new jobs and business opportunities within the dynamic life science sector of advanced industries.”

All inquiries should be directed to the ‘CID4 Search Committee’ at jobs@cid4.com. The deadline for applications is December 20, 2014. Principals only need apply, please.

About Kevin M. Smith, CID4 President/CEO

Smith was part of the team that founded CID4 in 2009. Prior to CID4, Smith was President of Gambro, Inc., the U.S. holding company for Gambro AB, the Sweden-based medical device and healthcare services company. He started his career with Arthur Young in New York and was a partner with Ernst & Young, leading the development of their Colorado life science practice at the time he left to join Gambro.

“While I will no longer be leading CID4, I will stay active in the Colorado life science community through my Board responsibilities at the Colorado BioScience Association, Donor Alliance and AlloSource, my service on the Centura Health Audit and Corporate Responsibility Committee and my investment activities at KMG Capital Partners LLC,” Smith said. “CID4’s success is grounded in the excellent technologies that are being developed in Colorado. We have invested approximately $3 million into nine early stage companies. Those firms have gone on to create 85 new jobs and raise an additional $30 million to support the commercialization of their patient-focused technologies. I am proud to have played a role in this process.”

About the Colorado Institute for Drug, Device and Diagnostic Development

Founded in 2009, the Colorado Institute for Drug, Device and Diagnostic Development (CID4) is a 501(c)(3) not-for-profit charitable organization whose mission is to advance the Colorado bioscience ecosystem through company creation and job growth. Active business management and capital work in tandem to help bridge the gap between discovery and product development. CID4 works to identify, fund and actively manage emerging life science technologies. This aim is achieved via an ongoing technology solicitation process augmented by additional deal flow sourcing through networked relationships. Active due diligence is provided by CID4 management in consultation with members of the CID4 Technical and Business Advisory Committee. For more information visit http://CID4.com

Contacts:

Kevin M. Smith, President/CEO CID4, http://CID4.com - kevin.smith@cid4.com, (720) 859-4047

Maggie Chamberlin Holben, APR, http://www.absolutelypr.com - maggie@absolutelypr.com, (303) 984-9801 or (303) 669-3558

Link to the PitchEngine social media release

Link to the PR.com posting

Saturday, November 22, 2014

Colorado BioScience November Focus Newsletter: Featuring DaVita Clinical Research & CBSA 2014 Award Winners

The November Colorado BioScience Focus Newsletter is now available, with DaVita Clinical Research as the Company Spotlight and a full overview of the 2014 CBSA Award Winners.

"DaVita Clinical Research (DCR) brings a track record of success to your Phase I studies. For more than 25 years, DaVita has helped over 150 biopharmaceutical and device clients successfully manage and execute early phase clinical trials in both healthy normal volunteers and patient populations. DaVita's integrated clinical data analysis and reporting offering allows for effective and timely decisions about safety and efficacy." Link to read full the article

Link to download the entire November Focus Newsletter.

Friday, November 14, 2014

Video Highlights: 2014 CBSA Awards Dinner

Colorado BioScience Association announced winners of its 11th annual industry awards at the Marriott City Center, Denver, on November 6th. The announcement is made by April Giles, CBSA President and CEO, who opened the evening with an overview of this year’s industry accomplishments. Giles was joined by 850 KOA’s Steffan Tubbs and CBSA Board Chair Derek Cole in announcing the winners. For more information, visit: http://www.businesswire.com/news/home/20141020005183/en/Colorado-BioScience-Association-Honors-Industry#.VGZWIvnF98E
 
Colorado Bioscience Industry: 2014 Accomplishments
http://youtu.be/GJAPrxe8Enc
 
CBSA Awards Emcee Steffan Tubbs Opening Remarks
http://youtu.be/P_f1wLPrUYg
 
Presentation of the 2014 Boettcher Investigators
http://youtu.be/LBcMi1Y6tVg
 
CBSA Awards 2014 Recipients

http://youtu.be/MFh5B2ibGKo
 
Chairman's Award: Derek Cole Presents
http://youtu.be/18fsXfwddrI
 
CBSA Lifetime Achievement: Dr Richard Duke Remarks
http://youtu.be/6FQ1yqz8T7s
 
Davis Phinney Introduction by Bob Reddy, Medtronic
http://youtu.be/xj5ggFi2rck
 
2014 CBSA Awards Keynote: Davis Phinney
http://youtu.be/Ux82IQayzPU
 
CBSA Awards 2014 Closing: Patients are the Reason
http://youtu.be/xj5ggFi2rck

Coverage overview: CBSA's 2014 Colorado Bioscience Industry Awards

Recapping "Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s ViroCyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award" coverage:








Link to CNBC.com








Link to BioSpace






Link to Yahoo! Finance






Link to News-Medical.net

Thursday, November 13, 2014

Xconomy: Colorado Bioscience "Companies Take a Bow"

Quoting from the November 7th edition:

"Colorado bioscience’s best: The Colorado BioScience Association also honored their industry’s leaders this week. AlloSource, which is a nonprofit organization based in Centennial, was named company of the year by the association.

AlloSource develops and distributes tissues that can be used in surgical procedures such as skin grafts and joint repair. It has more than 400 employees.

This year, AlloSource expanded its work in stem cell research and began using microbe detection technology developed by NASA’s Jet Propulsion Laboratory to improve tissue decontamination procedures. AlloSource’s hope is that the NASA technology will cut the time it takes to get donated tissue and organs to recipients.

Boulder-based ViroCyt won the award for rising star of the year. The company’s Virus Counter is able to calculate a virus’ growth rate in minutes and is used in vaccine and drug development, viral therapeutics, and protein expression research.

For a list of individual winners, click here."

Link to Xconomy

InnovatioNews: "CBSA's 11th annual awards presented to eight bioscience industry leaders and supporters"

Quoting from InnovatioNews:

"Colorado BioScience Association (CBSA) announced the winners of its 11th annual industry awards during a Thursday [Nov 6] celebration of the state’s bioscience industry at the Marriott City Center in downtown Denver.

April Giles, CBSA president and CEO, along with 850 KOA’s Steffan Tubbs and CBSA Board Chair Derek Cole, announced this year’s award winners:

Company of the Year – AlloSource 
Rising Star of the Year—ViroCyt 
Lifetime Achievement – Dr. Richard Duke 
Institute Leadership – Jim Rosa 
Business Partner of the Year—Phyllis Arthur 
Educator of the Year – Deborah Carnevale 
Volunteer of the Year – Amy Wedeking Shannon 
Chairman’s Award – Monisha Merchant 

In addition to the awards, the event included the Boettcher Foundation presenting its 2014 Class of Boettcher Investigators in the Webb-Waring Boiomedical Research Program."

Link to InnovatioNews

Tuesday, November 11, 2014

Beau Jo's Hosts Last Feasting for Felines of 2014 - Nov. 19 - five locations!

Cat Care Society's last Feasting for Felines for 2014 will be Wednesday, Nov. 19 at the five Front Range locations of Beau Jo's Pizza locations!

ARVADA - 7525 W. 53rd

BOULDER - 2690 Baseline Road

EVERGREEN - 28186 Highway 74

IDAHO SPRINGS - 1517 Miner Street

UNIVERSITY HILLS - 2710 S. Colorado Blvd.

Go to Beau Jo's for lunch, dinner, or take out on Nov. 19th, present this flyer, and 20% of proceeds will be donated to CCS!

You can get your pizza fix and help the Cat Care Society cats at the same time. Remember to print out and bring the flyer:
 

Monday, November 10, 2014

Colorado BioScience Association Showcases Industry’s Best at 2014 Awards Dinner Celebration

Colorado BioScience Association (CBSA) announced winners of its 11th annual industry awards at the Marriott City Center, Denver, on November 6. The announcement is made by April Giles, CBSA President and CEO, who opened the evening with an overview of this year’s industry accomplishments.

Giles was joined by 850 KOA’s Steffan Tubbs and CBSA Board Chair Derek Cole, announcing the following winners:

Company of the Year: AlloSource

AlloSource, based in Centennial, is committed to its success and growth in Colorado’s bioscience community. Expanding its Colorado headquarters by 90,000 square feet in 2012, the company continued the momentum in 2013 by launching a new proprietary allograft used in a broad range of soft tissue surgical procedures. Most recently in 2014, AlloSource announced two new partnerships which will expand their work in stem cell innovation as well as undertake a new project with NASA through the Space Act Agreement. This work will advance microbial research in tissue processing for various Mars missions. Visit: http://www.allosource.org . Finalists for Company of the Year were: Mountainside Medical, Boulder, http://mountainsidemed.com and Spectranetics, Colorado Springs, http://www.spectranetics.com.

Rising Star of the Year: ViroCyt 

ViroCyt, Boulder, launched the first Virus Counter in 2011, which has proven to be faster, more accurate and cost effective than traditional viral quantification methods with results in minutes instead of days or weeks. This year ViroCyt announced the introduction of the next generation Virus Counter at the World Vaccine Congress held in Washington, DC. The technology has already been adopted by the leading companies in the fields of viral vaccine development and therapeutic protein expression. Virocyt’s innovations are changing the landscape of virus detection technologies. Visit: http://virocyt.com. Finalists for Rising Star were: JustRight Surgical, Boulder, http://www.justrightsurgical.com and Silvergate Pharmaceuticals, Greenwood Village, http://www.silvergatepharma.com.

Lifetime Achievement: Dr. Richard Duke

Dr. Duke is an accomplished scientist with over 25 years of experience in cutting-edge biomedical research, and is a tenured faculty member in the Departments of Medicine and Immunology at the University of Colorado Denver. He has been instrumental in the development of Colorado’s bioscience industry as an executive, inventor, biomedical researcher and serial entrepreneur. Dr. Duke was involved in the formation and management of GlobeImmune, Newellink USA, ApopLogic Pharmaceuticals, Sierra Neuropharmaceuticals, PeptiVir, MenoGeniX and Aurora Oncology. He has also been integral to these Colorado-based companies, by raising more than $200 million in financing and helped bring multiple products to human clinical trials.

One of the Colorado bioscience industry’s proudest achievements was the creation of the BioScience Discovery Evaluation Grant Program (also referred to as BDEG). Dr. Duke was the visionary and driving force behind the development of BDEG, making the program what it is today. This initial concept in 2006 has now become a national model for state’s trying to cultivate a bioscience industry of their own.

Institute Leadership: Jim Rosa

During last year’s Awards Dinner, CBSA introduced a new award, the Institute Leadership award. This award was created to recognize outstanding efforts that further the Colorado Bioscience Institute’s mission of providing education, workforce and career development for life science professionals, companies, students and teachers. This year, CBSA honors one outstanding Institute champion, Jim Rosa, for his leadership on the workforce training programs. The workforce training programs involve partners with deep content expertise and a strong commitment to advancing knowledge and closing workforce gaps in Colorado’s bioscience eco-system.

Business Partner of the Year: Phyllis Arthur, BIO

CBSA’s 2014 Business Partner of the Year is Phyllis Arthur, Senior Director of Vaccines, Immunotherapeutics and Diagnostics Policy at the Biotechnology Industry Organization. Ms. Arthur was a remarkable partner for CBSA on Senate Bill 222, becoming the bioscience industry’s taskforce representative and also forging lasting relationships with the Colorado Department of Public Health and Environment, the Colorado Children's Immunization Coalition and many other stakeholders. In the end, the taskforce collectively - and unanimously – agreed to all of the recommendations for Colorado. Phyllis continues to remain involved during the implementation phase and will act as a resource providing national best practice models and allowing the State to leverage her relationships and knowledge base.

Educator of the Year: Deborah Carnevale

Deborah Carnevale is the Director of the Overland High School Biotechnology Program. Under her leadership, the school’s biotechnology program has received multiple grants and certifications. Students who have completed the program have an advantage when entering college. Their advanced research skills in biotechnology has enabled many of them to receive laboratory jobs as university freshmen, a rare opportunity. Her dedication and commitment to her students is commendable.

Volunteer of the Year: Amy Wedeking Shannon

Ms. Shannon is Principal Consultant for Caliber One Solutions and an active participant on CBSA’s Membership Committee. Her knowledge base and relationships in the community have proven to be very valuable to the membership efforts of CBSA. Her drive is tireless and capable when bringing new members into the organization. Amy also provides great leadership and insight through her recommendations to better the committee process. In the words of Committee Chair (and 2013 Volunteer of the Year) Dustin Whistler, the committee is very lucky to have her.

Chairman’s Award: Monisha Merchant

Monisha Merchant serves as Senior Policy Advisor to Senator Michael Bennet and has been a tremendous leader for the bioscience industry and the State as a whole. During the development of the 2011 America Invents Act, Senator Bennet co-authored a provision to establish three United States Satellite Patent and Trademark Offices. Ms. Merchant’s commitment to the goal of securing a satellite office in Colorado was truly commendable. She helped to spearhead the process and forged an incredible coalition of public and private partners which ultimately led to the selection of the Denver site. This achievement will not only better the entrepreneurs in the state and also across the region. Ms. Merchant also played an integral role in leveraging her influence and relationships to create the Blackstone Entrepreneurial Network (BEN) in Colorado. BEN links Master Entrepreneurs across industries and regions to support high growth entrepreneurial activities. Most recently, she facilitated the “Bioscience in Colorado” day where she and Senator Bennet invited key community leaders to explore the industry’s eco-system.

About the Awards Dinner 

The Awards Dinner began with a cocktail reception followed by dinner and the awards program. In addition, the Boettcher Foundation presented its 2014 Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program. The event closed with a keynote address by Olympic cycling medalist and Parkinson’s survivor Davis Phinney.

Phinney, diagnosed with Parkinson’s disease in 2000 at the age of 40, founded the Boulder-based Davis Phinney Foundation in 2004. Today, Phinney is both a role model in the cycling community and an inspiration to the estimated 1.5 million Americans and estimated 10 million worldwide who are currently living with the disease. Tens of thousands of people living with this disease have been directly touched by one of the Davis Phinney Foundation programs or through Davis Phinney’s inspirational message: “it is possible to live well with Parkinson’s today.” For more information, visit: http://www.davisphinneyfoundation.org and http://www.medtronicdbs.com/parkinsons/personal-stories/davis-phinney/index.htm.

Sponsors of the Awards Dinner included: Boettcher Foundation; Cooley, LLP; Fisher Scientific, Fitzsimons Redevelopment Authority, Medtronic and Terumo BCT.

Link to the Business Wire Newswire

Link to the PitchEngine Social Media Release

Friday, November 07, 2014

Mark Your Calendar: Cat Care Society is again part of Colorado Gives Day (Tue, Dec. 9th)

Cat Care Society needs your support on Tuesday, Dec. 9, 2014, when thousands of donors will come together to support Colorado non-profits like ours. Last year, a record-breaking $20.9 million was donated to Colorado non-profits via Colorado Gives.

This year, thanks to Community First Foundation and First Bank, Colorado Gives Day features a $1 million incentive fund, one of the largest gives day incentive funds in the country. Every non-profit receiving a donation on Colorado Gives Day receives a portion of the incentive fund. Please help us by marking your calendar for Dec. 9 and making a donation on Colorado Gives Day.

Special Note: Beginning Nov. 1, donations can be scheduled ahead of time to be made on Dec. 9 for Colorado Gives Day.

Link to donate, click the "CO GIVES DAY" button under donation type to arrange for your Colorado Gives Day donation in advance.

Lakewood Pet Examiner: 'Cat Care Society announces Endowment Challenge Grant'

Quoting from Carrie Dow's November 3 posting:

"The Cat Care Society has partnered with Community First Foundation, the same foundation that created Colorado Gives Day, to create a permanent endowment fund for the non-profit and provide care to cats and community for years to come.

Over the summer Community First Foundation held a challenge for the cats-only shelter in Lakewood. If the shelter could raise $20,000 for the endowment, the foundation would provide an additional grant of $10,000 for a total of $30,000. That goal was reached with the help of some generous anonymous donors.

This endowment fund will be held in perpetuity and a portion of it can be used each year to support the shelter’s mission. Various uses include helping the shelter’s continuing efforts to serve the community and its cats, to help provide a steady stream of revenue during the ups and downs of the economy and to raise the shelter’s credibility by showing the community that is it fiscally responsible and financially sound."

Link to Examiner.com

For more information about the new endowment program, contact Mary Jo Baker, Director of Major and Planned Gifts for Cat Care Society, 303.298.9680 ext. 15, or MBaker@CatCareSociety.org.

Thursday, November 06, 2014

Mark Your Calendar: the 2014 Santa Paws Festival is coming to Cat Care Society

The annual Santa Paws Festival at the Cat Care Society shelter is Friday, Dec. 5, noon to 5 p.m., and Saturday, Dec. 6, 9 a.m. to 4:30 p.m. 'Santa Paws' is Cat Care Society’s annual bake sale and craft bazaar (plus more). This year the festival features:
  • Santa Paws (played by Dave Genco). 
  •  Baked goods for purchase – best sellers include homemade candies, cookies, bar cookies, and pies; home-canned items such as pickles’ james and jellies; boxed cupcakes; Bundt cakes and other cakes that can be wrapped without destroying frosting; spiced nuts and fudge. 
  • Free refreshments, including popcorn sweets, and our Famous Cathouse Punch. 
  • Meow Mart at its best. 
  • Hand-crafted items for sale. 
  • Jingle Cats. 
  • Jackie Green, face painter, back for a second year on Saturday only, starting at 11 (first come, first served). 
  • A raffle/drawing for great gift items.